The goal of the ADVANCE project is to help health professionals, regulatory agencies, public health institutions, vaccine manufacturers and the general public make more informed decisions on benefits and risks of marketed vaccines.



ADVANCE Blueprint submitted to IMI

The WP7 deliverable D7.7 Blueprint of a framework to rapidly provide... READ MORE


ADVANCE was presented at the Vaccine Conference 2018

On the 17th of September Professor Miriam Sturkenboom delivered the lecture... READ MORE


ADVANCE at the 2018 Big Data for Pharmacovigilance conference

The Big Data for Pharmacovigilance conference took place in London on 20-21st... READ MORE


ADVANCE consortium has developed the ADVANCE Toolbox which can be used by the scientific community to streamline the monitoring of the health benefits and risks of vaccines in the post licensure phase. It comprises different online open source applications that allow to transform outcome definitions into diagnosis codes, to analyse and select vaccine codes in a given vaccine coding system, assess potential impact of possible disease- and exposure misclassification, derive prevalence estimates and validity indices and visualise near real-time monitoring of the post-marketing benefits and risks of vaccines. Moreover, researchers can use ADVANCE web catalogue to conduct an assessment of the ability of databases to contribute to future vaccine benefit-risk studies.